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Instrumentation   
NMR measurements were performed on Varian instruments at 400 or 500 MHz for proton spectra, 161 MHz for 
phosphorous NMR, and 100 or 125 MHz for carbon spectra.  Chemical shifts are given in ppm values and are not 
solvent referenced unless otherwise noted.  Gas chromatography (GC) was performed on a Shimadzu GC-17A 
instrument equipped with an FID detector.  The columns used were an HP-5 column (Agilent, 30 m x 0.32 mm x 
0.25 m film) and a CyclosilB column (Agilent, 30 m x 0.32 mm x 0.25 m film, with a 10 m x 0.32 mm inert glass 
SGE guard column).  Absorbance data from 96-well microtitre plates was collected on a Tecan infinite M200.  
Proteins were purified on an ÄKTAxpress with 5 ml HisTrap columns (GE Healthcare Life Sciences).  
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General Procedures   
Reactions performed under Ar were done using flame dried glassware and standard syringe and septa techniques 
unless otherwise noted.  Removal of solvent in vacuo refers to use of a Büchi rotary evaporator.  Reagents were 
purchased from VWR, Fisher, or Aldrich and generally used without purification.  TLC was performed with 
aluminum-backed silica gel 60 F254 analytical plates from EMD.  Visualization of compound spots was done with a 
short wave UV lamp followed by staining with anisaldehyde.  Flash chromatography was performed on Geduran 
silica gel 60 (40-63 m) from EMD.  Alcohol oxidase (AOX) was obtained from MP Biomedicals.  Farnesyl 
diphosphate (FPP) was synthesized from farnesol according to the method of Poulter.
1
  Primers were purchased 
from Integrated DNA Technologies (IDT).  E. cloni Express electrocompetent E. coli BL21 (DE3) was purchased 
from Lucigen.  Alkaline phosphatase, Taq polymerase, T4 ligase, and restriction enzymes DpnI, XhoI, and NdeI 
were purchased from New England Biolabs (NEB).  BcBOT2 and SSCG_02150 in pET28a(+) were gifts from 
David E. Cane at Brown University.  TB refers to terrific broth from RPI, and LB refers to Luria broth from the 
same vendor. 
 
Synthesis of substrate 3 
Overview of the synthetic scheme: 
 
Aldehyde 8 is a known compound, and was made from commercial farnesol acetate according to published 
procedures.
2
  
 
(2E,6E)-11-methoxy-3,7-dimethylundeca-2,6,10-trien-1-ol (9) 
 
The Wittig reagent (methoxymethyl)triphenylphosphonium chloride (9.9 g, 28.9 mmol) was suspended in 90 mL of 
dry THF in a 250 mL flame-dried round bottom flask under Ar.  Potassium t-butoxide (3.23 g, 28.8 mmol) was 
added in one portion, and the reaction was magnetically stirred at room temp for 15 min.  The reaction mixture 
(deep red at this point) was cooled with an ice bath.  A solution of aldehyde 8 (4.5 g, 14.5 mmol) in 45 mL of dry 
THF was added dropwise as the ice bath cooling and magnetic stirring were continued.  The cooling bath was then 
removed, and the reaction was stirred at room temp for 45 min.  The reaction was quenched with aqueous NH4Cl, 
and the product was extracted into hexanes with ca. 5% EtOAc.  The organic layer was washed with water and 
brine, dried over sodium sulfate, and concentrated in vacuo.  Ph3PO was removed by trituration in pentane, and the 
filtered pentane solution was concentrated in vacuo to give a nearly colorless liquid.  This liquid was dissolved in 55 
mL of dry THF under Ar in a septum-sealed 250 mL round bottom flask.  The solution was magnetically stirred at 
room temp as 24 mL of 1 M TBAF in THF was added via syringe.  The reaction was stirred for 3 h at room temp.  
The reaction mixture was then partitioned between Et2O and water, and the organic phase was washed with brine 
and dried over sodium sulfate.  The organic phase was concentrated in vacuo, and the residue was purified by silica 
gel chromatography using EtOAc in hexanes (1:3) with 1% triethyl amine.  The product was collected as a viscous 
colorless liquid.  Yield: 2.79 g (86%). 
1
H NMR (400 MHz, C6D6)   6.29 (d, J = 12.6 Hz, 0.78 H, major isomer), 5.71 (dt, J = 6.2, 1.5 Hz, 0.49 H, minor 
isomer), 5.41-5.37 (m, 1 H), 5.24-5.17 (m, 1 H), 4.73-4.61 (m, 0.66 H, major isomer), 4.43-4.38 (td, J = 7.2, 6.3 Hz, 
0.40 H, minor isomer), 4.02-3.94 (m, 2 H), 3.18 (s, 1.76 H), 3.12 (s, 1.08 H), 2.46-2.38 (m, 1 H), 2.17-2.06 (3 H), 
2.05-1.93 (m, 5 H), 1.57 (s, 1.03 H), 1.53 (s, 1.68 H), 1.47-1.43 (2 overlapping s, 3 H). 
13
C NMR (101 MHz, C6D6) δ 
147.26, 146.18, 137.72, 137.51, 134.88, 134.47, 124.70, 124.56, 124.37, 124.06, 106.05, 102.09, 58.98, 58.60, 
55.08, 40.99, 39.77, 39.47, 39.45, 26.38, 26.28, 26.22, 22.72, 15.74, 15.66, 15.56.  HRMS (EI+) m/z: (M+) found 
224.1777, calc for C14H24O2 224.1776. 
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 ((2E,6E)-11-methoxy-3,7-dimethylundeca-2,6,10-trienyloxy)diphosphate (3)
1 
 
Step 1: A 250 mL flame dried round bottom flask was charged with the alcohol 9 (1.0 g, 4.5 mmol) and dry DMF 
(50 mL).  LiCl (1.89 g, 45 mmol) was added, and the mixture was magnetically stirred at room temp under Ar as 
sym-collidine (5.0 mL, 38 mmol) was added.  Stirring was continued until a solution formed.  The reaction was then 
cooled with an ice bath until it became cloudy.  Mesyl chloride (1.05 mL, 13.6 mmol) was then added dropwise, and 
the reaction was stirred for 90 min in the ice bath.  The reaction mixture was partitioned between pentane and water.  
The pentane layer was washed four times with aqueous copper (II) sulfate, once with brine, and once with saturated 
aqueous sodium bicarbonate.  The organic layer was dried over sodium sulfate and concentrated in vacuo to give a 
colorless liquid.   
Step 2: In a separate 250 mL round bottom flask under Ar was combined flame dried crushed 3 Å molecular sieves 
(8 g), tris(tetra-n-butylammonium) hydrogen pyrophosphate (6.3 g) and 40 mL of dry acetonitrile.  The combination 
of the components was exothermic, and an ice bath was used for several minutes to keep the reaction from 
overheating.  The residue from step 1 was dissolved in 10 mL of dry acetontrile, and was added via syringe to the 
reaction.  The reaction was stirred for 90 min at room temp.  The reaction mixture was then filtered through a coarse 
sintered glass filter, followed by a second filtration through a medium frit sintered glass filter.  Slight cloudiness 
remained in the filtrate.  The filtrates were washed with pentanes, and then were concentrated in vacuo.  The 
remaining thick caramel-colored residue was dissolved in about 10 mL of anion exchange buffer (2.0 g NH4HCO3 in 
water with 2% isopropanol), and was passed through a 4 x 15 cm Dowex 50W-X8 (100-200 mesh, ammonium 
form) column using more anion exchange buffer.  The anion exchange buffer was passed through the column slowly 
with gravity, and the first 100 mL of eluent was collected and lyophilized overnight.  The resulting solid was 
triturated with methanol (5 x 10 mL) to extract the product.  The methanol extract was concentrated in vacuo, and 
the off-white solid product was subjected to azeotropic removal of methanol.  The solid was treated with 
dichloromethane, followed by removal of solvents in vacuo.  It was important to mix the solid and dichloromethane 
well with a spatula until a gel-like consistency was obtained.  This azeotrope was conducted 3-4 times, followed by 
removal of remaining solvent under high vacuum (ca. 1 mmHg) for 3 h.  The remaining solid was stored at -20 °C 
until use.  Yield: 0.82 g (42%).   
1
H NMR (400 MHz, CD3OD)  6.03 (d, J = 12.4 Hz, 0.57 H, major isomer), 5.63 (app. d, J = 6.4 Hz, 0.24 H, minor 
isomer), 5.18 (t, J = 6.4 Hz, 1 H), 4.90-4.85 (m, 1 H), 4.48-4.42 (m, 1 H), 4.26 (t, J = 6.6 Hz, 2 H), 3.29 (s, 0.70 H, 
minor isomer), 3.20 (s, 1.9 H, major isomer), 1.90-1.84 (m, 3 H), 1.80-1.70 (m, 5 H), 1.44 (s, 3 H), 1.35 (s, 3 H).  
13
C NMR (101 MHz, CD3OD) 148.3, 140.8, 135.9, 125.4, 122.3, 107.0, 103.5, 63.8, 56.1, 42.2, 40.7, 27.50, 27.39, 
23.4, 16.5, 16.1.   
31
P NMR (161 MHz, CD3OD) -9.39 (d, J = 19 Hz), -10.0 (d, J = 18 Hz).  HRMS (ES-) m/z: (the 
alkyl diphosphate anion of 3 was observed as the doubly protonated form with a single negative charge) found 
383.1025, calc for C14H25O8P2 383.1007. 
 
Overexpression and purification of BcBOT2 and SSCG_02150  
The proteins were overexpressed in BL21(DE3).  An overnight culture (10 mL) at 37 °C in TB containing the 
corresponding antibiotic was used to inoculate 1L of TB with the antibiotic. After 4 hours of growth at 37 °C and 
250 rpm, the temperature was dropped to 25 °C and protein production was induced with addition of IPTG up to an 
end concentration of 100 μM. After 16 hours of incubation the cells were harvested by centrifugation at 5000 x g 
and 4 °C for 20 minutes. The cell pellets were resuspended in three volumes per cell pellet mass of 20 mM Tris pH 
7.6, 300 mM NaCl, 5 mM DTT, 20 mM imidazole and frozen at -20°C overnight. Subsequent to thawing, the cells 
were lysed by sonication. The lysate was then cleared by centrifugation at 25000 x g for 30 minutes and filtering 
through a 0.2 μm filter. Since the enzymes were hexahistidine-tagged, the soluble fraction of the cell lysate was 
passed through a Ni-NTA column and washed with 20 mM Tris pH 7.6, 300 mM NaCl, 5 mM DTT, 20 mM 
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imidazole. The proteins were eluted from the column using a gradient running up to 20 mM Tris pH 7.6, 300 mM 
NaCl, 5 mM DTT, 500 mM imidazole. For BcBOT2, the fractions containing protein were pooled and the buffer 
was exchanged to 50mM PIPES, 10mM MgCl2, 100mM NaCl, 2 mM DTT, pH 7.6. After addition of 25% glycerol 
(end concentration), the SSCG_02150 was aliquoted, frozen on dry ice and stored at -80 °C until further use.  
The proteins were tested for production of their natural compounds in GC-scale reactions (see below) with FPP as 
the substrate.  The identity of the product of the BcBOT2 reaction was confirmed by scaling up the reaction, 
isolating the product, and confirming its identity by NMR.  The GC-scale reaction of SSCG_02150 with FPP in the 
presence of 10% betaine gave a single product as expected, and the product was not further characterized.  The 
products are shown below. 
 
 
Bioreactions for GC analysis 
A 2 mL GC vial was placed on ice.  Standard buffer was added first, followed by purified enzyme, and then by a 10 
mM solution of either surrogate substrate 3 or FPP.  The total volume of these three components totaled 500 L, and 
the volumes changed depending on the experiment.  A typical experiment to test the fidelity of the product mixture 
of the enzymes with FPP includes 10 L of enzyme (100 M stock solution, for a final concentration of 2 M), 15 
L of FPP (10 mM stock solution in 25 mM NH4HCO3), and 475 L standard buffer (or alternative buffer if noted).  
The reaction is overlayed with 500 L of pentante, hexanes, or EtOAc containing 200 M dodecane as an internal 
standard.  The reaction is sealed with a septum cap, and incubated at the desired temp and time.  The reactions are 
worked up by vortexing, separating the layers (by centrifugation when required), and filtering the organic layer 
through a plug of sodium sulfate.  The filtrate is placed in a GC-vial containing a low-volume insert, and is then 
analyzed by GC.   
 
Preparatory scale reaction of synthetic substrate 3 
In a 250 mL glass bottle, 100 mL of standard buffer (50 mM PIPES, 10 mM MgCl2, 100 mM NaCl, 2 mM DTT, pH 
7.5) was combined with 200 L of purified BcBOT2 (100 M stock solution, 0.2 M final concentration) and 4 mL 
of substrate 3 (10 mM stock solution in 25 mM NH4HCO3, 0.4 mM final concentration, 0.04 mmol).  The reaction 
mixture was overlayed with 100 mL of pentane, and the reaction was sealed and left at room temp without stirring.  
After 24 h, another portion of 200 L of BcBOT2 was added, followed by another 100 L portion the following day 
(both 100 M stock solution).  After a total of 72 h, the reaction was worked up by saturating the aqueous layer with 
NaCl, shaking vigorously, and separating the layers.  The organic layer was dried over Na2SO4, filtered, and 
concentrated to a few mL in vacuo with the rotary evaporator bath filled with ice water.  Final removal of the 
solvent was done under a stream of Ar in a 20 mL vial on ice to give the product as a colorless semi-solid.  Yield: 
about 6 mg (~75% yield).  Germacrenes and similar compounds are a mixture of several conformations in solution, 
making NMR spectra of these compounds very complex and rarely amenable to deconvolution.
3
  The NMR spectra 
of 7 is similar to that of germacrenes in reference 4, and is shown below.  Additionally, there is the expected peak in 
the aldehyde range and no remaining methoxy peaks.  Furthermore, the identity of 7 is supported by its thermal 
rearrangement behavior below.  HRMS (EI+) m/z: (M+) found 192.1564, calc for C13H20O 192.1514. 
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Cope rearrangement of 7 
The terpene germacrene A and similar structures are known to undergo Cope rearrangements upon exposure to 
heat.
3
  These Cope rearrangements occur in the injection ports of GC instruments when these ports are heated to 
near or at 250 °C.  By analogy, product 7 was expected to rearrange to a diasteromeric mixture of aldehydes in a hot 
injector port.      
 
Figure S1. a) Proposed Cope rearrangement of 7.  b) Analogous known Cope rearrangement of germacrene A into 
elemene.  
 
The ability of 7 to undergo a Cope rearrangement was explored to support the identity of the product.  The injector 
temperature of the GC was set at 195, 210, and 250 °C for three successive injections of 7.  The GC runs were done 
on an HP-5 column with the initial temp held at 60 °C for 4 min, and then a temp ramp of 15 °C per min to 280 °C 
followed by a 3 min hold at this temp.  With the injector at 195 °C, GC analysis of 7 showed predominantly one 
product with an elution time of about 11.2 min, with a minor amount of two products eluting at around 10 min 
(Figure S2).  Upon raising the temperature to 210 °C, the initially predominant product increasingly rearranged to 
the two formerly minor peaks.  Further heating to 250 °C resulted in almost complete rearrangement of the peak at 
11.2 min to the two peaks at about 10 min.  These data support the identity of the peak at 11.2 min as product 7, 
which is then transformed by high temperatures into the two smaller peaks at around 10 min (corresponding to the 
two Cope product diastereomers indicated in Figure S1 a). 
 
Figure S2. Thermal rearrangement of 7 in the GC injector port. Injector temp: 250 °C in back, 210 °C in the middle, 
195 °C in front.  
 
Assay validation with methanol standards 
A dilution series was made by dissolving known concentrations of methanol (from 16 to 500 M) in buffer (50 mM 
PIPES, 10 mM MgCl2, 100 mM NaCl, 1 mM DTT, pH 7.5).  The dilution series was put into a 96-well microtiter 
plate with three repeats per concentration, and 200 L of total volume per well.  Then 10 L per well of a solution 
of dilute alcohol oxidase (AOX, 50 L of AOX stock solution dissolved in 950 L of the same buffer from above) 
was added.  The microtiter plates were shaken at room temp for 5 min at 600 rpm on a table top shaker, and then left 
to react undisturbed for 5 min more.  Purpald
®
 solution (Aldrich, 351 mg dissolved in 15 mL of 2 N NaOH, 50 L 
per well) was added and shaking was resumed for about 5 min, and then the plates were left undisturbed for 30 min.  
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S6 
 
The plates were briefly centrifuged at 5000 rpm to remove bubbles, and the absorbances of the wells were read with 
a plate reader at 550 nm.  
 
Figure S3. Screen response for methanol standards 
 
Materials 
Standard Buffer: 50 mM PIPES, 10 mM MgCl2, 100 mM NaCl, 2 mM DTT, pH 7.6 
Lysis Buffer:  Standard buffer, 0 .5 mg/mL Lysozyme, 0.02 mg/mL DNase I 
Dilute AOX: AOX Stock solution from frozen stock (MP Biomedicals) dissolved in 950 L of 100 mM KPi, pH 
8.0. 
Purpald Solution: 351mg solid Purpald
®
 (Aldrich) in 15 ml 2N NaOH 
EDTA: 0.5 M pH 8.0 aqueous (NaOH to adjust pH) 
Surrogate 3 stock solution: 10 mM Surrogate 3 in 25 mM NH4HCO3 .  This stock solution is stable for at least 
several months if frozen at -20 °C, or at least several weeks if stored at 4 °C. 
 
Screening for thermostability 
Libraries of 96-well deep well plates stored at – 20 °C containing cell pellets were thawed for 20 – 30 min and then 
treated with 300 L per well of lysis buffer (50 mM PIPES, 10 mM MgCl2, 100 mM NaCl, 2 mM DTT, pH 7.6, 0.5 
mg/mL lysozyme, 0.02 mg/mL DNase I).  The cell pellets were resuspended by vortexing, and the plates were 
incubated at 37 °C for 60 min.  The cell debris was separated by centrifugation at 5000 x g at 4 °C for 15 min, and 
100 L from each well was transferred to 96-well PCR plates.  The PCR plates were sealed with Microseal B film 
from Bio-rad and then placed in a thermocycler or water bath for 10 min at a temperature which was optimized to 
almost complete inactivation of BcBOT2.  After this heat treatment, the PCR plates were immediately placed on ice.  
The seals were removed, and each well was treated with 100 L of 0.5 mM surrogate substrate 3 in standard buffer 
(50 mM PIPES, 10 mM MgCl2, 100 mM NaCl, 2 mM DTT, pH 7.6).  This solution was made immediately prior to 
use.  The reactions were aged at room temp for 1-2 h, and then the contents of the PCR plates were transferred to 96-
well microtiter plates.  Then 10 L per well of a solution of dilute alcohol oxidase (AOX, 50 L of AOX stock 
solution from MP Biomedicals dissolved in cold 950 L of 0.1 M potassium phosphate buffer pH 8.0) was added.  
The microtiter plates were shaken at room temp for 10 min at 600 rpm on a table top shaker.  Purpald
®
 solution 
(Aldrich, 351 mg dissolved in 15 mL of 2 N NaOH, 50 L per well) was added and shaking was resumed for 30 
min.  The plates were briefly centrifuged at 3-5000 rpm to remove bubbles, and the absorbances of the wells were 
y = 0.0048x + 0.0413 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0 50 100 150 200 250
A
b
so
rb
an
ce
 a
t 
5
5
0
 n
m
 
M Methanol 
S7 
 
read with a plate reader at 550 nm. Background absorbance was typically 0.2 or below, with active enzymes 
sometimes giving absorbances exceeding 1. 
 
Figure S4. An example of a 96-well microtiter plate with wells containing active terpene synthases indicated by the 
blue-purple color of the product. 
 
Growth of libraries 
A library of BcBOT2 mutants was made by error-prone PCR using primers BcBOT2Fwd and BcBOT2RevV2.  The 
template was the BcBOT2 gene in pET28a(+) vector as supplied by David E. Cane, and Taq (Roche) was used in 
the supplied buffer for reactions along with 200 M MnCl2 and 0.4 mM of each dNTP (dNTP mixture from Roche).  
These conditions gave a mutation rate of 3 base pair mutations per gene.  The insert obtained from this epPCR was 
digested with DnpI (NEB) to remove remaining template, and the insert was double digested with XhoI and NdeI 
(both NEB).  The vector pET28a(+) was double digested with XhoI and NdeI, and was dephosphorylated with calf 
intestinal phosphatase (NEB).  Gel purification was used after each digestion, and a gel extraction kit (Promega) was 
used to isolate the DNA.   Ligation of the insert and backbone was carried out with T4 ligase (NEB) at 16 °C 
overnight, and the DNA was isolated with a clean and concentrate kit (Zymo Research).  Electro-competent BL21 
(DE3) cells were transformed with 1 L of the cleaned ligation mixture, and individual colonies were picked by 
hand using toothpicks into 96-well shallow well plates (1 mL volume) containing 300 L per well of LB media 
containing 0.05 mg/mL of kanamycin.  The colonies were grown overnight at 37 °C with shaking at 225 rpm and 
80% rh.  Then, 50 L aliquots of culture were transferred to wells in 96-well deep well plates containing 800 mL per 
well of media (LB for the intitial library, TB for subsequent libraries) containing 0.05 mg/mL of kanamycin.  At this 
time, cryostocks of the libraries were made in 96-well microtitre plates in 20% glycerol.  In the deep well expression 
plates, the cultures were grown at 37 °C for 4 h, and then the temperature was reduced (to 18 °C for the initial 
library, 25 °C for subsequent libraries).  At the same time the protein production was induced with 50 L per well of 
IPTG in LB media for a final IPTG concentration of 0.5 mM.  Shaking was continued for 24 h, and then the cells 
were pelleted by centrifugation at 3000 g for 10 min at 4 °C.  The plates containing cell pellets were frozen at -20 °C 
overnight or longer until beginning the screening protocol.   
 
T50 determinations 
T50 data were obtained by filling a row in a 96-well PCR plate with 100 L per well of enzyme at 4 M in standard 
buffer.  The PCR plate was sealed with Microseal B film, and a thermocycler was used to apply a temperature 
gradient for 10 min.  The PCR plate was then immediately cooled on ice.  Then, 100 L of 0.5 mM surrogate 
substrate 3 in standard buffer was added, and the reactions were allowed to react at room temp or 30 °C for 1 h.  The 
screening protocol using AOX and Purpald
®
 was conducted as described.  The T50 values were estimated as the 
temp at which the remaining active enzyme produced half the screen response, above background, as the maximum 
response of the non-denatured enzyme. 
 
Product specificity analysis 
The mutants were overexpressed and purified in the same manner as for BcBOT2, and the purified enzymes were 
used in bioreactions on a GC scale as described above.  The product specificity of the mutants was compared to 
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BcBOT2 using FPP as substrate.  The same product dominated, as seen in Figure S5, and only baseline side 
products were observed.  
 
Figure S5. Gas chromatography traces of products from BcBOT2 and mutants. BcBOT2 in back, 19B7 middle, 9D6 
in front. 
 
Comparing the relative levels of protein expression  
Equal amounts (as measured by OD600) of E. coli BL21(DE3) expressing the protein of interest were mixed in 1:1 
ratio with SDS-PAGE sample buffer containing 500 mM TRIS pH 7.5, 600 mM glycine, 20% (v/v) glycerine, 4% 
(w/v) SDS and 50 μl/ml β-mercaptoethanol and incubated at 95°C for 10 minutes. After separation of the proteins on 
an Any kD™ Mini-PROTEAN® TGX™ Precast Gel (Bio-rad), the protein bands were stained with Coomassie Blue 
and the gel was digitalized. The corresponding picture was processed with ImageJ.
4
 The lanes on the gel were 
converted into graphs, where the peak area corresponding to the protein of interest was integrated. The amount of 
protein loaded was normalized to a prominent band around 43kDa, most likely corresponding to E. coli EF-Tu. 
 
 
Figure S6. Expression of BcBOT2 and 19B7 as determined by imaging of an SDS-Page gel.  The amounts of 
produced protein are statistically indistinguishable.  This analysis was not carried out for 9D6, but the amounts 
obtained from 1 L expression cultures after purification were equal to or better than BcBOT2 on all of the several 
occassions when 9D6 was expressed. 
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Correlation of screen response with product formation for 19B7 
In 2 mL GC vials on ice were combined standard buffer (489 L), FPP (10 L of a 10 mM stock solution for a final 
concentration of 200 M), 19B7 (0.5 L of a 100 M stock solution in standard buffer, freshly thawed on ice, final 
concentration of 100 nM), and an overlayer of ethyl acetate (500 L with 200 M dodecane as an internal standard).  
The vials were then placed in a water bath at 29.5°C.  At each time point, a vial was taken out and vortexed.  The 
vial was placed on ice and 250 L of the overlayer was filtered through a plug of sodium sulfate into a GC vial with 
an insert, and the sample was analysed by GC using a CyclosilB column.  The temperature program began with a 
four minute hold at 75°C, followed by a ramp of 8.0°C per min to 250°C and a final hold at 250°C for 3 min.  The 
product was quantified by corrected areas under the curve comparison to authentic product standards.  A total of five 
analyses were done for each time point. 
 
In a 20 mL scintillation vial in an ice bath was combined standard buffer (3.9 mL), 80 L of 3 (10 mM of stock, for 
a final concentration of  200 M), and 4 L of 19B7 (100 M stock solution in standard buffer, freshly thawed on 
ice, final concentration 100 nM).  Immediately, the vial was placed in a water bath at 29.5°C.  At each time point, 3 
aliquots of 185 L were removed and placed into individual wells of a microtiter plate and were mixed with 15 L 
of 0.50 M EDTA (pH 8.0).  After all of the time points were sampled, the AOX-Purpald
®
 treatment was done as 
described for the assay.  The responses were converted to methanol concentrations, after subtracting out 
background, by normalizing to the data in the section ‘assay validation with methanol standards.’ 
 
Optimizing conditions for 02150 expression, lysis, and reactions  
Single colonies of E. coli BL21 containing 02150 in pET-28a(+) were picked into a 96 well shallow well plate 
containing 300 L of LB kan per well.  The plate contained several blank wells.  The plate was fitted with a plastic 
lid shaken overnight at 37 °C at 225 rpm and 80% rh.  This plate was then used to inoculate 4 deep well 96-well 
plates containing 800 L of LB kan in the top half of the plate and TB kan in the bottom.  Innoculation was done 
with 40 L per well of the starter culture.  The plates were grown for 4 h at 37 °C at 225 rpm shaking and 80% rh.  
Then, two of the plates were cooled to 25 °C and the other two were cooled to 18 °C.  All plates were induced with 
50 L of 9.0 mM IPTG in LB kan, and shaking was continued for 24 h at either 18 or 25 °C at 225 rpm without 
humidity control.  The plates were then centrifuged at 3000 xg for 10 min at 4 °C, and the media was discarded.  
The plates containing the cell pellets were stored overnight or longer at – 20 °C. 
 
The cell pellets in deep well 96-well plates obtained above were thawed at RT for about 20 min, and the cell pellets 
were then resuspended in 300 L of lysis buffer containing either no additive, or 10% w/v of either sucrose or 
betaine.  The suspensions were incubated for 1 h at 37 °C, and the cell debris was then pelleted at 5000 g for 15 min 
at 4 °C.  From each well of the plates, 100 L of lysate was transferred to the corresponding wells in microtiter 
plates.  To these wells was added 100 L of standard buffers with the same additives, if any, as in the lysis step.  
Additionally, these buffers contained 0.50 mM of 3.  The plates were sealed with Microseal B film and incubated for 
37 °C for about 70 min.  The screening protocol of AOX and Purpald
®
 was carried out as described in the 
experimental section.  Results are displayed in Table 1. 
 
Confirmation of 02150 optimization by GC reactions 
A 96-well plate of E. coli BL21 containing 02150 in pET-28a(+) was picked from individual colonies and expressed 
at 25 °C as in the preceding section.  The frozen cell pellets were thawed, and were resuspended in 300 L of lysis 
buffer containing either 10% w/v betaine or no betaine.  The plate was incubated at 37 °C for 1 h, and the cell debris 
was then pelleted by centrifugation at 5000 xg at 4 °C for 15 min.  Aliquots of 100 L of lysate were transferred to 
wells in a 96-well microtitre plate.  Then 100 L per well of standard buffer containing 0.50 mmol of either FPP or 
3 was added.  The microtiter plate was sealed with Microseal B film and was incubated at 37 °C for 2 h.  Then, the 
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contents of 3 wells per each condition were combined into a 1.7 mL centrifuge tube and extracted with 500 L of 
hexanes.  After vortexing briefly, the hexane layer separated and 250 L of this layer was filtered through a plug of 
sodium sulfate into a GC vial containing a low-volume insert.  GC analysis was done on the HP-5 column with the 
initial temp held at 75 °C for 6 min, then a temp ramp of 9.0 °C per min to 174 °C, then a second temp ramp of 
35.0 °C per min to 280 °C followed by a 3 min hold at this temp.  Each condition is represented by an average of 
three samples, and the relative product amount is shown in Figure S7 as uncorrected areas-under-the-curve. 
 
 
Figure S7. Relative product formation of 02150 with FPP and 3 in the presence and absence of 10% w/v betaine. 
 
 
Primers 
BcBOT2Fwd: GCAGCCATCATCATCATCATCACAGCAGCG 
 
BcBOT2RevV2: GTGGTGGTGCTCGAGTTATGCAACTACAG 
 
 
Nucleotide sequences 
 
BcBOT2 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCAAT
CCCAGCACTGGAGCCGCAACTGCACGACGCGGATACGTCCTCCAACAACATGAGCTCCAACTCCACTG
ATTCTGGCTACGACACCAACTCTACGACCCCGCTGGAAAAATCTGAAAAGCCGAACACCCAGGAACTG
AAACAACAACAGCTGGACCCGAAACGTCCGCCGTTCGTTCGTGTTCCGGACCTGTTCGGTAGCATCAT
GTCTACCAAACCAGTTGTAAACCCGAACTACTTCGCTGCCAAAGCTCGTGGCGACCGTTGGATCGCTC
GTGTAATGAACTTCAACAAAGCAGTTGCGGCACGCAACTCTAAAGTGGACCTGTGCTTCCTGGCGAGC
ATGTGGGCTCCGGATGCACCAGAGGACCGTCTGGTTATGATGCTGGATTGGAACCACTGGGTATTTCT
GTTTGATGACCAGTTCGATGAAGGTCACCTGAAAGAAGATCCGGCAGCTGCTGCTGAAGAAGTCAAAC
AGACTATCGCAATTATGGGCGGTAACGCTCCACGTTACACGGCAGAATCCAACCCGATTCGTTACGTC
TTCCAGCAGTGTTGGGATCGTCTGAAAGCGGTGTCTTCCCAGGAAATGCAACAACGCTGGATCGATCA
GCATAAACGTTACTTCGACCAGCTGCTGGTGCAAGTGGATCAGCAGGTTGGTGGTGAAAACTTCACGC
GTGACGTTGAGGCATATATGGACCTGCGTCGCGGTACCATCGGTGTATACCCGGCAATCTCTCTGTCTG
AATACGGCGCTGGTGTGAATGTTCCACAGCATGTCTACGATCACCCGAGCCTGCAGGAATGTATGAAA
GTCAGCGCAGACCTGGTGACCCTGGTGAACGATGTGCTGAGCTATCGTAAAGACCTGGAACTGGGTGT
CGATCACAATCTGATGTCCCTGCTGATGCAGCGTGATAACCTGTCCGCGCAGCAGGCGGTTGACGTAA
TCGGCGACATGGTTAACGAATGCTACCGTCGTTGGTATCTGGCTCTGGCAGAGCTGCCGTCTTACGGTG
AGAAAATCGACTATAACGTGATGAAATTTGTCGAAATTTGCCGTGCTGTTGCGCAGGGCAACCTGTAT
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TGGAGCTTCCAGACCGGCCGTTACCTGGGTCCGGAAGGTCACGAAGTGCACGAAACCGGCATCATGTA
CCTGCCGCCGGCGGCGAACCTGGTAGTTGCATAA 
 
19B7 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCAAT
CCCAGCACTGGAGCCGCAACTGCACGACGCGGATACGTCCTCCAACAACATGAGCTCCAACTCCACTG
ATTCTGGCTACGACACTAACTCTACGACCCCGCTGGAAAAATCTGAAAAGCCGAACACCCAGGAACTG
AAACAACAACAGCTGGACCCGAAACGTCCGCCGTTCGTTCGTGTTCCGGACCTGTTCGGTAGCATCAT
GTCTACCAAACCAGTTGTAAACCCGAACTACTTCGCTGCCAGAGCTCGTGGCGACCGTTGGATCGCTC
GTGTAATGAACTTCAACAAAGCAGTTGCGGCACGCAACTCTAAAGTGGACCTGTGCTTCCTGGCGAGC
ATGTGGGCTCCGGATGCACCAGAGGACCGTCTGGTTATGATGCTGGATTGGAACCACTGGGTATTTCT
GTTTGATGACCAGTTCGATGAAGGTCACCTGAAAGAAGATCCGGCAGCTGCTGCTGAAGAAGTCAAAC
AGACTATCGCAATTATGGGCGGTAACGCTCCACGTTACACGGCAGAATCCAACCCGATTCGTTACGTC
TTCCAGCAGTGTTGGGATCGTCTGAAAGCGGTGTCTTCCCAGGAAATGCAACAACGCTGGATCGATCA
GCATAAACGTTACTTCGACCAGCTGCTGGTGCAAGTGGATCAGCAGGTTGGTGGTGAAAACTTCACGC
GTGACGTTGAGGCATATATGGACCTGCGTCGCGGCACCATCGGTGTATACCCGGCAATCTCTCTGTCTG
AATACGGCGCTGGTGTGAATGTTCCACAGCATGTCTACGATCACCCGAGCCTGCAGGAATGTATGAAA
GTCAGCGCAGACCTGGTGACCCTGGTGAACGATGTGCTGAGCTATCGTAAAGACCTGGAACTGGGTGT
CGATCACAATCTGATGTCCCTGCTGATGCAGCGTGATAACCTGTCCGCGCAGCAGGCGGTTGACGTAA
TCGGCGACATGGTTAACGAATGCTACCGTCGTTGGTATCTGGCTCTGGCAGAGCTGCCGTCTTACGGTG
AGAAAATCGACTATAACGTGATGAAATTTGTCGAAATTTGCCGTGCTGTTGCGCAGGGCAACCTGTAT
TGGAGCTTCCAGACCGGCCGTTACCTGGGTCCGGAAGGTCACGAAGTGCACGAAACCGGCATCATGTA
CCTGCCGCCGGCGGCGAACCTGTAG 
 
9D6 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCAAT
CCCAGCACTGGAGCCGCAACTGCACGACGCGGATACGTCCTCCAACAACATGAGCTCCAACTCCACTG
ATTCTGGCTACGACACTAACTCTACGACCCCGCTGGAAAAATCTGAAAAGCCGAACACCCAGGAACTG
AAACAACAACAGCTGGACCCGAAACGTCCGCCGTTCGTTCGTGTTCCGGACCTGTTCGGTAGCATCAT
GTCTACCAAACCAGTTGTAAACCCGAACTACTTCGCTGCCAGAGCTCGTGGCGACCGTTGGATCGCTC
GTGTAATGAACTTCAACAAAGCAGTTGCGGCACGCAACTCTAAAGTGGACCTGTGCTTCCTGGCGAGC
ATGTGGGCTCCGGATGCACCAGAGGACCGTCTGGTTATGATGCTGGATTGGAACCACTGGGTATTTCT
GTTTGATGACCAGTTCGATGAAGGTCACCTGAAAGAAGATCCGGCAGCTGCTGCTGAAGAAGTCAAAC
AGACTATCGCAATTATGGGCGGTAACGCTCCACGTTACACGGCAGAATCCAACCCGATTCGTTACGTC
TTCCAGCAGTGTTGGGATCGTCTGAAAGCGGTGTCTTCCCAGGAAATGCAACAACGCTGGATCGATCA
GCATAAACGTTACTTCGACCAGCTGCTGGTGCAAGTGGATCAGCAGGTTGGTGGTGAAAACTTCACGC
GTGACGTTGAGGCATATATGGACCTGCGTCGCGGCACCATCGGTGTATACCCGGCAATCTCTCTGTCTG
AATACGGCGCTGGTGTGAATGTTCCACAGCATGTCTACGATCACCCGAGCCTGCAGGAATGTATGAAA
GTCAGCGCAGACCTGGTGACCCTGGTGAACGATGTGCTGAGCTATCGTAAAGACCTGGAACTGGGTGT
CGATCACAATCTGATGTCCCTGCTGATGCAGCGTGATAACCTGTCCGCGCAGCAGGCGGTTGACGTAA
TCGGCGACATGGTTAACGAATGCTACCGTCGTTGGTATCTGGCTCTGGCAGAGCTGCCGTCTTACGGTG
AGAAAATCGACTATAACGTGATGAAATTTGTCGAAATTTGCCGTGCTGTTGCGCAGGGCAACCTGTAT
TGGAGCTTCCAGACCGGCCGTTACCTGGGTCCGGAAGGTCACGAAGTGCGCGAAACCGGCATCATGTA
CCTGCCGCCGGCGGCGAACCTGTAG 
 
 
 
 
Protein sequences 
Mutated positions with respect to BcBOT2 are in underlined. 
 
BcBOT2 
MGSSHHHHHHSSGLVPRGSHMAIPALEPQLHDADTSSNNMSSNSTDSGYDTNSTTPLEKSEKPNTQELKQQ
QLDPKRPPFVRVPDLFGSIMSTKPVVNPNYFAAKARGDRWIARVMNFNKAVAARNSKVDLCFLASMWAP
DAPEDRLVMMLDWNHWVFLFDDQFDEGHLKEDPAAAAEEVKQTIAIMGGNAPRYTAESNPIRYVFQQCW
DRLKAVSSQEMQQRWIDQHKRYFDQLLVQVDQQVGGENFTRDVEAYMDLRRGTIGVYPAISLSEYGAGV
S12 
 
NVPQHVYDHPSLQECMKVSADLVTLVNDVLSYRKDLELGVDHNLMSLLMQRDNLSAQQAVDVIGDMVN
ECYRRWYLALAELPSYGEKIDYNVMKFVEICRAVAQGNLYWSFQTGRYLGPEGHEVHETGIMYLPPAANL
VVA 
 
 
19B7 
MGSSHHHHHHSSGLVPRGSHMAIPALEPQLHDADTSSNNMSSNSTDSGYDTNSTTPLEKSEKPNTQELKQQ
QLDPKRPPFVRVPDLFGSIMSTKPVVNPNYFAARARGDRWIARVMNFNKAVAARNSKVDLCFLASMWAP
DAPEDRLVMMLDWNHWVFLFDDQFDEGHLKEDPAAAAEEVKQTIAIMGGNAPRYTAESNPIRYVFQQCW
DRLKAVSSQEMQQRWIDQHKRYFDQLLVQVDQQVGGENFTRDVEAYMDLRRGTIGVYPAISLSEYGAGV
NVPQHVYDHPSLQECMKVSADLVTLVNDVLSYRKDLELGVDHNLMSLLMQRDNLSAQQAVDVIGDMVN
ECYRRWYLALAELPSYGEKIDYNVMKFVEICRAVAQGNLYWSFQTGRYLGPEGHEVHETGIMYLPPAANL 
 
9D6 
MGSSHHHHHHSSGLVPRGSHMAIPALEPQLHDADTSSNNMSSNSTDSGYDTNSTTPLEKSEKPNTQELKQQ
QLDPKRPPFVRVPDLFGSIMSTKPVVNPNYFAARARGDRWIARVMNFNKAVAARNSKVDLCFLASMWAP
DAPEDRLVMMLDWNHWVFLFDDQFDEGHLKEDPAAAAEEVKQTIAIMGGNAPRYTAESNPIRYVFQQCW
DRLKAVSSQEMQQRWIDQHKRYFDQLLVQVDQQVGGENFTRDVEAYMDLRRGTIGVYPAISLSEYGAGV
NVPQHVYDHPSLQECMKVSADLVTLVNDVLSYRKDLELGVDHNLMSLLMQRDNLSAQQAVDVIGDMVN
ECYRRWYLALAELPSYGEKIDYNVMKFVEICRAVAQGNLYWSFQTGRYLGPEGHEVRETGIMYLPPAANL 
 
 
References 
 
 [1] V. J. Davisson, A. B. Woodside, T. R. Neal, K. E. Stremler, M. Muehlbacher, C. D. Poulter, J. Org. Chem. 
2006, 5, 4768-4779.  
[2] a) R. P. Hanzlik, Org. Syntheses. 1988, Coll. Vol. 6, p. 560; 1977, Vol. 56, p. 112.  b) Labadie, G. R.; 
Viswanathan, R.; Poulter, C. D. J. Org. Chem. 2007, 72, 9291-9297. 
[3] a) J.-W. de Kraker, C. R. Franssen, A. de Groot, W. A. Konig, H. Bouwneester, Plant Physiol. 1998, 117, 
1381-1392.  b) J. A. Faraldos, S. Wu, J. Chappell, R. M. Coates, Tetrahedron 2007, 63, 7733-7742.  c) O. 
Cascon, S. Touchet, D. J. Miller, V. Gonzalez, J. A. Faraldos, R. K. Allemann, Chem.Commun. 2012, 48, 
9702-9704.  d) J. A. Faraldos, Y. Zhao, P. E. O’Maille, J. P. Noel, R. M. Coates, ChemBioChem 2007, 8, 1826-
1833.  e) D. J. Miller, F. Yu, D. W. Knight, R. K. Allemann, Org. Biomol. Chem. 2009, 7, 962-975.  f) D. J. 
Miller, F. Yu, R. K. Allemann, ChemBioChem 2007, 8, 1819-1825.  g) W. N. Setzer, J. Mol. Model. 2008, 14, 
335-342. 
[4] Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://rsb.info.nih.gov/ij/, 1997-2008. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S13 
 
NMR Spectra 
 
9 
1
H NMR (400 MHz, C6D6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S14 
 
9 
13
C NMR (101 MHz, C6D6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S15 
 
3 
1
H NMR (400 MHz, CD3OD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S16 
 
3 
31
P NMR (161 MHz, CD3OD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S17 
 
3 
13
C NMR (101 MHz, CD3OD) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S18 
 
7 
1
H NMR (500 MHz, toluene-d6) 
 
 
 
